Ara-C Enhances Mitochondrial Activities in Human Leukaemic Cells
Author Information
Author(s): P. Muus, C. Van den Bogert, H. De Vries, A. Pennings, M. Holtrop, C. Haanen
Primary Institution: Nijmegen University Hospital
Hypothesis
Does Ara-C enhance mitochondrial activities in human leukaemic cells?
Conclusion
Ara-C treatment increases mitochondrial activities in human leukaemic cells without affecting cell proliferation.
Supporting Evidence
- Ara-C treatment led to a 3-fold increase in cytochrome c oxidase activity in G1 phase cells.
- Respiration rates in Ara-C treated cells were significantly higher than in control cells.
- Cells treated with Ara-C showed an increased accumulation of mitochondrial-specific dye.
Takeaway
When a special drug called Ara-C is given to leukaemia cells, it helps the cells' power factories, called mitochondria, work better, even though it stops the cells from growing.
Methodology
The study involved culturing human leukaemic Molt 4 cells with Ara-C and measuring mitochondrial activities and enzyme levels.
Limitations
The study does not establish a causal relationship between enhanced mitochondrial activities and the cytotoxic effects of Ara-C.
Participant Demographics
Human leukaemic cells (Molt 4 cell line)
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website